Scientists have made a significant discovery about the mutations that drive cancer growth, potentially revealing a weakness that can be targeted for treatment. The findings may offer a roadmap for treating cancer tumors and could lead to new ways to halt aggressive cancer growth. However, the specifics of the discovery and its implications are still unclear, with some reports suggesting the identification of a common cancer mutation and others referencing a new type of dna damage or a protein network map.